ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Overview
All American Pet Company, Inc. and its consolidated subsidiaries (“AAPT”) develops and markets innovative first-to-market pet wellness products including super-premium dog food bars, dog food snacks and antibacterial paw wipes.
The executive offices are located at 1100 Glendon Avenue, 17
th
Floor, Los Angeles, California 90024. The office telephone number is (310) 689-7355.
The Company’s online sites are
www.allamericanpetcompany.com
,
www.nutrabar.com
,
www.pawtizer.com
,
www.facebook.com/nutrabar
,
www.facebook.com/pawtizer
,
www.vetresearchlibrary.com
,
http://issuu.com/nutrabar
and
http://bewelllivelong.wordpress.com
The information on our websites are not, and shall not be deemed to be, a part of this report or incorporated by reference into this or any other filing we make with the Securities and Exchange Commission (the “SEC”)
History of the Company and its Current Status
All American Pet Company, Inc. was initially organized under the laws of the State of New York (“All American Pet Company, Inc. NY”) in February 2003. In January 2006, All American Pet Company, Inc. NY merged into All American Pet Company, Inc. a Maryland Corporation (“All American Pet Company, Inc. MD”). In June 2012, All American Pet Company, Inc. MD merged into a Nevada Corporation, (“All American Pet Company, Inc.”).
The Company has formed a number of wholly owned subsidiaries to provide for accountability of each of its operations. All American PetCo, Inc. was formed in January 2008 to provide corporate infrastructure and management services. All American Pet Brands, Inc. was formed in April 2009 to be the Company’s manufacturing and warehousing operation. In September 2009, the Company signed a license and distribution agreement with AAP Sales and Distribution, Inc., a third party company, that obtained the rights to sell certain of the Company’s products on a non-exclusive basis. AAP Sales and Distribution, Inc.’s operations have been consolidated with All American Pet Company, Inc. based on accounting guidelines for Variable Interest Entities.
In 2010 and 2011, AAPT produced, marketed, and beta tested two super-premium dog foods under the brand names Grrr-nola® Natural Dog Food and Chompions®. We believe that both Grrr-nola® Natural Dog Food and Chompions® were the first dog food products that were formulated for canine heart health and endorsed by a veterinary cardiac surgeon.
In 2012, after the beta testing, the Company completed market research, proprietary scientific formulation and testing for an all-natural super premium bar category called NutraBar™ - original, low fat and senior formulas. It also produced proprietary formulations for two additional bars – Chomp Bar™ and Mutt Bar™. It has successfully launched its portable, convenient and functional NutraBar™ line of all natural true food super premium bars to both online and traditional brick and mortar retailers. Each gluten-free 4 ounce bar has a kCal equivalent of 8 ounces of super-premium dry dog food. The bars have been both manufactured and packaged by the Company since the fourth quarter 2012 and related sales commenced in 2013.
The Company has shown and announced to the U.S. market the first line of all-natural super premium dog treats called CHEWIES™, which comes in three flavors, and is preparing to market its CHEWIES™ line of flavored all-natural super-premium 27% protein dog treats.
During 2012, the Company also launched its PAWtizer™ line of wet wipes and spray, the pet care industry’s first alcohol-free, anti-bacterial dog cleaner.
The Company has never operated at a profit and is dependent upon additional financing to remain a going concern. Throughout 2012, the Company obtained equity capital in the amount of approximately $3,000,000 and continues to seek additional equity capital to sustain operations. During the three months ended September 30, 2013, the Company obtained $651,498 of equity capital and borrowed $82,807 from its CEO and President under the terms of a convertible note to sustain operations. The Company remains under significant financial strain, primarily because of its limited operating funds and a significant amount of past due debts. The limited amount of operating capital may preclude the Company’s ability to execute its manufacturing, marketing, and distribution objectives or to continue operations. As a result, the reports of the independent registered public accounting firms on the Company’s 2012 and 2011 consolidated financial statements include explanatory paragraphs expressing substantial doubt regarding the Company’s ability to continue as a going concern.
Products
The Company has developed a number of innovative pet wellness products. The Company is also in the process of developing new products, variations of existing products and other items that will complement and enhance the Company’s array of product offerings. The Company requires significant additional financing to market, manufacture and sell its existing products and to develop new products. Key components of the Company’s product offerings are described below:
NutraBar™
The Company has developed and launched in 2013 the pet industry’s first dog food product packaged as a nutritional food bar. With three product lines targeting the super-premium dog food and dog treat segments,the Company’s all-natural bars are the equivalent of 8 ounces of dry kibble in a 4 ounce bar. These bars offer a high protein meal or snack without the inconvenience of bags and bowls. AAPT’s true food bars are formulated to contain a blend of natural ingredients and provide essential nutrients optimized to promote a dog’s nutrition, health, and vitality.
CHOMPBar™
The line contains 27% protein quad segmented 4 ounce bars with digestive fiber enhancements in addition to functional vitamin and mineral supplementation. It comes in original, low fat and senior formulas.
MUTTBar™
Mutt™Bar products contain 25% protein and are supplemented with omega 3 fatty acid to promote healthy skin and coat. They are fortified with vitamin and amino acids. The bars will also be a quad-segmented 4 ounce wrapped bar available singly, as well as in full-color display cartons of a dozen. They also come in original, low fat, and senior formulas.
CHEWIES™
The Company’s line of 27% high protein dog snacks will be made with the same nutritive ingredients as the food bars with additional flavorings added. CHEWIES™ will be packaged in 8 ounce and 14 ounce re-sealable pouches containing approximately 32 and 64 bite sized pieces.
PAWtizer™
The Company developed PAWtizer™ for the purpose of protecting the 53 million American families that are homes to 78 million dogs from infectious human germs such as MRSA, E. coli, Salmonella and other bacteria that are innocently picked up by dogs and transferred to humans. PAWtizer™ is the pet care industry’s first alcohol-free anti-bacterial dog cleaner. With PAWtizer™, the Company is delivering a product that research has shown to be more useful and effective than alcohol. PAWtizer™ is available in canisters of 100 and 45 count, chemically treated wet wipes that have been shown to kill 99.9% of the germs resident on a typical dog paw. PAWtizer™ also comes in a convenient 8 ounce spray with Bitrex® added. Bitrex® is a “bittering” agent that will prevent dogs from licking their paws and thus extending the reach of the antibacterial effects of PAWtizer™.
The principal active ingredient in PAWtizer™ products is 0.13% Benzalkonium chloride, a germ reducing agent that has been widely accepted for use as a topical antiseptic for human cuts and scrapes and “leave on skin” cosmetics.
LIQUIDITY AND CAPITAL RESOURCES
Our liquidity requirements arise principally from our working capital needs, including the cost of goods, inventory, marketing, officer compensation and payroll and general and administrative costs. In the future, we intend to fund our liquidity requirements through a combination of cash flows from operations and external financings.
Our principal sources of liquidity have been sales of equity securities and borrowings. To meet our current requirements to operate, the Company has sold unregistered common stock and is currently attempting to undertake the sale of additional equity securities. As new funds are obtained, our principal uses of capital are to meet our operating requirements, production, marketing and advertising expenditures, and make investments in inventory and equipment. Additional funds could be used to reduce past due payroll taxes and other debts and payables. Until cash generated from operations is sufficient to satisfy our future liquidity requirements, we will be investigating purchase order and accounts receivable funding from different sources, as well as other sources of capital. We will also be looking to seek equity capital through the issuance of additional common stock.
On February 12, 2013, the Company entered into an unsecured, Convertible Promissory Note (the “Convertible Note”) with an unrelated third party for $103,500. The Convertible Note bears interest at 8% per annum and a balloon payment of principal and accrued interest is due on November 12, 2013. At any time 180 days after the date of the Convertible Note, the lender can convert the principal and accrued interest into shares of the Company’s common stock at a 39% discount based on the average of the lowest three trading prices during a ten day period ending one day prior to the conversion date. Pursuant to the terms of the Convertible Note, the Company must meet all of its filing requirements with the Securities and Exchange Commission. During the period, the Company did not comply with this provision and as a result the Convertible Note went into default. As provided for in the Convertible Note, it became a demand note and demand was made, the amount due became $159,390 which amount is composed of 150% of the principal amount or $155,250 which amount is composed of the principal amount of $103,500 and the default interest amount of $51,750, and the accrued interest of $4,140. During the quarter ended September 30, 2013, the entire principal amount of $103,500 together with $6,500 of interest for an aggregate amount of $110,000 was converted into 49,341,200 shares of the Company’s common stock. Further, as of October 22, 2013, the balance of $49,390 in interest was converted into 36,751,282 shares of the Company’s common stock. Finally, the intrinsic value of the beneficial conversion feature associated with the Convertible Note was $78,204 which amount was recorded as debt discount on the commitment date. As a result of the conversion of the entire principal and interest due, the Company fully amortized the debt discount during the period ended September 30, 2013 and $78,204 in debt discount was recognized as interest expense during the period ended September 30, 2013.
On September 17, 2013, the Company entered into an unsecured, Convertible Promissory Note (the “Convertible Note”) with an unrelated third party for $103,500. The Convertible Note bears interest at 8% per annum and a balloon payment of principal and accrued interest is due on June 19, 2014. At any time 180 days after the date of the Convertible Note, the lender can convert the principal and accrued interest into shares of the Company’s common stock at a 39% discount based on the average of the lowest three trading prices during a ten day period ending one day prior to the conversion date. The intrinsic value of the beneficial conversion feature associated with the Convertible Note was $66,172 which amount was recorded as debt discount on the commitment date and will be amortized over the life of the Convertible Note. For the period ended September 30, 2013 the Company recorded $3,808 of the debt discount as interest expense. Subsequent to the quarter ended September 30, 2013, during November 2013, the Company did not comply with a requirement to meet all of its filing requirements with the Securities and Exchange Commission, and as provided for in the Convertible Note, it became a demand note and demand was made during November 2013. The amount due became $159,390 which amount is composed of 150% of the principal amount or $155,250 which amount is composed of the principal amount of $103,500 and the default interest amount of $51,750, and accrued interest of $4,140. The Company has made no payments on the Convertible Note.
As of September 30, 2013, one other source for funding was the $1,000,000 credit facility commitment from the Company’s, Chief Executive Officer, Barry Schwartz, and President, Lisa Bershan, provided to the Company in March 2012. On March 1, 2013, this credit facility was renewed with the following changes to the terms: Interest rate was lowered to 6.5% per year and the maturing date was amended to be due and payable not later than 48 months from the original issue date of the Revolving Grid Note. As of September 30, 2013, advances to the Company under this facility totaled $624,064 with $15,106 in accrued interest, increasing the holders’ beneficial ownership by 290,531,696 shares of common stock. The Company’s need for significant future funding will likely result in significant additional dilution to our stockholders.
The terms of the Grid Note provide that the conversion price be lowered upon the occurrence of certain defined events. Notwithstanding this fact, the embedded conversion right is not required to be bifurcated from the host debt instrument, as the underlying common stock is not deemed to be readily convertible to cash (Accounting Standards Codification 815-15-25-51) based on management’s evaluation of the trading volume of the Company’s common stock and the lock up provisions of the Grid Note.
The conversion price of the Grid Note was below the closing market price of the Company’s common stock at the time of related borrowings. As a result, the Company recognized beneficial conversion features, which were limited to the amount of the Grid Note borrowings of $624,064. The beneficial conversion features are being amortized to interest expense over the term of the Grid Note (March 2016). During the nine months ended September 30, 2013, interest expense related to the amortization of beneficial conversion features totaled $76,980.
During the nine months ended September 30, 2013, the Company raised $1,113,731 of equity capital before offering costs. The Company is currently seeking additional sources of funding.
Because of our lack of funding and limited ability to adequately market our products, the Company has incurred high costs in manufacturing and marketing our products. Further, the Company has incurred significant costs, including officer compensation, occupancy and public company costs. As a result, we have experienced large operating losses and negative cash flow. The Company has funded its operations primarily through the issuance of equity securities and debt. Additional capital infusions will be needed to manufacture, distribute and promote our products, sustain operations and make payments and settlements of existing debts and obligations. The Company believes that its future profitability will depend on the commercial and consumer acceptance of its products, effective marketing strategies, efficient production and proper execution of its business plan, as to all or any of which, no assurance can be given. Additionally, success with its external financing strategies will be needed to effectuate our business plans. The Company’s limited operating history makes it difficult to evaluate prospects of success, particularly because its business plan is founded on new and unproven products. Furthermore, there can be no assurance that the Company’s external financing strategies will yield any capital or the amount of capital necessary to execute its business plan.
Results of Operations for the Nine Months Ended September 30, 2013 and 2012
The following discussion of the results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and notes thereto for the nine month period ended September 30, 2013 and 2012 included in this Quarterly Report as well as the statements included in our Form 10-K for the year ended December 31, 2012.
The Company’s expenses have increased dramatically in relation to sales as the Company is launching new products and preparing for future growth. For the nine months ended September 30, 2013, net sales were $198,454 which is attributable to the introduction of the NutraBar™ product line and a significant sale of Pawtizer during the three months ended September 30, 2013. Cost of goods sold were $883,122 during the same period. Our negative gross margin results from our sales being insufficient to cover certain fixed production costs and from sales of Pawtizer for an amount below cost. Net sales and cost of sales for the same period in 2012 were $16,885 and $8,688, respectively.
During the three months ended September 30, 2013, we completed a sales transaction to a third party customer in the aggregate amount of $140,049 for 35,100 units of our Pawtizer product. The terms of the sales transaction agreed upon were 60-day payment and free on board shipping (i.e. buyer pays for shipping). The customer maintains a US satellite office and warehouse, and after receiving the product, shipped it oversees for sale. As of March 2014, we have not yet received payment for the product and thus have not recognized the $140,049 as revenue. The customer has indicated that they intend to make payment. In the future, if payment is received or conditions change to better indicate the likelihood of collectability, we will recognize as revenue the $140,049.
Sales and marketing expenses increased $21,388, from $248,523 to $269,911, for the nine months ended September 30, 2012 and 2013, respectively. Higher expenses in the first nine months of the current year are primarily due to product development, testing, and promotion of the NutraBar™ product line while the Company was in early stages of NutraBar™ development. General and administrative expenses increased $3,273,710, from $1,337,745 to $4,611,455, for the nine months ended September 30, 2012 and 2013. This increase is attributable almost exclusively to $3,077,729 of non-cash stock based compensation expenses to various consultants in exchange for consulting and advisory services, and to a lesser extent, payroll and facility expenses as well as increases to legal, consulting and commission expenses.
Other expenses increased to $401,641 during the nine months ended September 30, 2013, primarily as a result of increased interest expenses associated with convertible notes and the related party Grid Note, including the amortization of related beneficial conversion features.
As a result of the above, our net loss for the nine months ended September 30, 2013 of $5,967,675 increased by $4,358,789 relative to the nine months ended September 30, 2012.
Results of Operations for the Three Months Ended September 30, 2013 and 2012
The following discussion of the results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and notes thereto for the three month period ended September 30, 2012 and 2013 included in this Quarterly Report as well as the statements included in our Form 10-K for the year ended December 31, 2012.
The Company’s expenses have increased dramatically in relation to sales as the Company is launching new products and preparing for future growth. For the three months ended September 30, 2013, net sales were $84,963, which is attributable to the NutraBar™ product line and a significant sale of Pawtizer during the quarter. Cost of goods sold were $766,792 for the same period. The negative gross margin is reflective of the Pawtizer sale for an amount below cost and our sales being insufficient to cover certain fixed production costs. Net sales and cost of sales for the same period in 2012 were $5,955 and $3,174, respectively.
During the three months ended September 30, 2013, we completed a sales transaction to a third party customer in the aggregate amount of $140,049 for 35,100 units of our Pawtizer product. The terms of the sales transaction agreed upon were 60-day payment and free on board shipping (i.e. buyer pays for shipping). The customer maintains a US satellite office and warehouse and after receiving the product shipped it oversees for sale. As of March 2014, we have not yet received payment for the product, and thus have not recognized the $140,049 as revenue. The customer has indicated that they intend to make payment. In the future, if payment is received or conditions change to better indicate the likelihood of collectability, we will recognize as revenue the $140,049.
Sales and marketing expenses increased $69,338, from $70,790 to $140,128, for the three months ended September 30, 2012 and 2013, respectively. Higher expenses in the current year period are primarily due to product development, testing, and promotion of the NutraBar™ product line while the Company was in early stages of NutraBar™ development. General and administrative expenses increased $2,782,111, from $588,196 to $3,370,307, for the three months ended September 30, 2012 and 2013. This increase is attributable almost exclusively to non-cash stock based compensation expenses of $3,077,729 to various consultants in exchange for consulting and advisory services.
Other expenses increased to $201,014 during the three months ended September 30, 2013, primarily as a result of increased interest expenses associated with convertible notes and the related party Grid Note, including the amortization of related beneficial conversion features.
As a result of the above, our net loss for the three months ended September 30, 2013 of $4,393,278 increased by $3,638,362 relative to the three months ended September 30, 2012.
Critical Accounting Estimates
Our unaudited interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. Preparation of these statements requires management to make judgments and estimates. Some accounting policies have a significant impact on amounts reported in these financial statements. A description of accounting policies that are considered critical may be found in our Annual Report on Form 10-K for the year ended December 31, 2012, filed with the SEC on June 17, 2013, in Part II, Item 7 under the heading “Critical Accounting Policies/Estimates.” In addition, refer to Note 1 to the consolidated interim financial statements included in Part I, Item 1 of this report for a summary of our significant accounting policies.
Recent Accounting Pronouncements
We do not believe that any recent accounting pronouncements will have a material impact on the Company’s consolidated financial statements.
Off-Balance Sheet Arrangements
Other than the lease commitments described in Note 11 to our September 30, 2013 unaudited condensed consolidated financial statements, we have no off-balance sheet arrangements that have or are likely to have a current or future effect on our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.
Forward Looking Statements
This Quarterly Report contains forward-looking statements. These forward-looking statements include, but are not limited to, predictions regarding:
|
•
|
|
the commercial viability of our products;
|
|
•
|
|
the effects of competitive factors on our products;
|
|
•
|
|
expenses we will incur in operating our business and revenues we will earn in operating our business;
|
|
•
|
|
our liquidity and sufficiency of existing cash;
|
|
•
|
|
the success of our financing plans; and
|
|
•
|
|
the outcome of existing, pending or threatened litigation.
|
You can identify these and other forward-looking statements by the use of words such as “may”, “will”, “expects”, “anticipates”, “believes”, “estimates”, “continues”, or the negative of such terms, or other comparable terminology. Forward-looking statements also include the assumptions underlying or relating to any of the foregoing statements.
Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth below under the heading “Risk Factors”. All forward-looking statements included in this document are based on information available to us on the date hereof. We assume no obligation to update any forward-looking statements.
The information contained in this Quarterly Report is as of September 30, 2013, unless expressly stated otherwise.
Item 4. Controls and Procedures.
Our management, with the participation of the Company’s Principal Executive Officer and Principal Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can only provide reasonable assurance of achieving the desired control objectives and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on such evaluation, the Company’s Principal Executive Officer and Principal Financial Officer have concluded that as of September 30, 2013, the Company’s disclosure controls and procedures were not effective, at the reasonable assurance level, in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act and in ensuring that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company’s management, including the Chief Executive Officer and Principal Financial and Accounting Officer, as appropriate to allow timely discussions regarding required disclosure due to the material weaknesses described below.
In light of the material weaknesses described below, we performed additional analysis and other post-closing procedures to ensure that our consolidated financial statements were prepared in accordance with generally accepted accounting principles. Accordingly, we believe that the financial statements included in this report fairly present, in all material respects, our consolidated financial condition, results of operations, changes in stockholders’ equity and cash flows for the periods presented.
|
·
|
Inadequate resources
.
The Company did not consistently maintain a sufficient complement of personnel with an appropriate level of accounting knowledge, SEC experience and training to (i) ensure the timely and accurate preparation of interim and annual financial statements in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP), (ii) effectively segregate certain incompatible functions, and (iii) remediate previously communicated deficiencies. In addition, the Company placed substantial reliance on manual procedures and detective controls that lacked adequate management monitoring for compliance.
|
|
·
|
Control environment
.
We did not maintain an effective control environment. Specifically, we did not maintain: (i) a documented risk assessment process that adequately addresses COSO objectives, (ii) sufficient anti-fraud controls, including a whistleblower program, formal written policies and procedures for the review and approval of transactions with related parties, a qualified and independent audit committee, and directors that are independent of management, (iii) adequate monitoring of existing controls over financial reporting and individual and corporate performance against expectations, (iv) appropriate human resource policies, such as background investigations and consistent performance reviews for key personnel, and (v) adequate documentation of actions taken by the Board regarding: fraud oversight, review and approval of external financial statements, actions supporting executive performance and compensation.
|
|
·
|
Period-end financial reporting processes
. Effective controls over period-end financial reporting processes were not maintained to effectively ensure: (i) significant agreements, or amendments thereto, are analyzed and accurately accounted for in the proper period, (ii) key reconciliations, account analyses, and summaries are performed and approved with appropriate resolution of reconciling items in a timely manner, (iii) journal entries, both recurring and non-recurring, are analyzed and approved, (iv) the resulting financial information, statements and disclosures are reviewed and appropriate checklists are used for compliance with U.S. GAAP, (v) monthly closing quality control checklists were used consistently and thoroughly to ensure all financial reporting procedures and controls were performed, and (vi) documented reviews of financial results are compared to budgets and expectations.
|
|
·
|
Cash expenditures.
Effective controls related to expenditures were not maintained. Specifically, controls were not properly designed or operating effectively to ensure: (i) officer compensation, including benefits, are authorized, reviewed and approved on a timely basis, and are in accordance with contractual agreements and (ii) expenditures made by management contained adequate and appropriate supporting documentation to establish the related business purpose of the expenditure.
|
Changes in Internal Control over Financial Reporting
There have not been any changes in the Company’s internal control over financial reporting (as such term is defined in Rules 13-15(f) and 15d-15(f) under the Exchange Act) during the nine months ended September 30, 2013 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
PART II. OTHER INFORMATION
Item 1. Legal Proceedings.
The Company is involved in various litigation involving vendors, former employees, and a promissory noteholder.
Vendors
As of December 31, 2011, one vendor had a settlement agreement for $20,000. As of September 30, 2013 no payments have been made.
During 2012, six vendors made claims or were awarded judgments against the Company for a total of $364,473. Also during the year ended December 31, 2012, a payment of $2,000 was made to one of the vendors which payment fulfilled that claim in full. The balance outstanding to the remaining five vendors at September 30, 2013 and December 31, 2012 was $362,473. On July 23, 2012, one of the vendors filed an action against the Company and certain officers as individuals for an original $150,000 judgment previously awarded in arbitration, which bears 4.75% interest, $49,950 in legal fees, and $4,981 in other fees. A court has not heard this action. The Company has recognized $221,463 in its September 30, 2013 and December 31, 2012 consolidated balance sheets relating to this matter.
Former Employees
As of December 31, 2011, six former employees made claims or were awarded judgments against the Company for a total of $211,961. During 2012, one former employee entered into a settlement agreement for $50,000, and there were no payments. The balance outstanding at September 30, 2013 and December 31, 2012 was $254,292 and $268,245, respectively, and includes accrued interest.
On April 6, 2010, the Company settled litigation with one of the six former employees. Terms of the settlement required the former employee to place 400,000 shares of Company stock valued at $52,000 in an escrow account in exchange for an initial payment of $8,000 and 27 monthly payments of $1,571. The Company will receive the shares of common stock after all of the payments have been made. The Company made no payments during the nine months ended September 30, 2013, no payments in 2012, and $3,342 in 2011. The outstanding balance at September 30, 2013 was $31,432.
On February 3, 2011, through mediation, the Company settled litigation with one of the former six former employees. Terms of the settlement required the former employee to place 750,000 shares of Company stock valued at $90,000 in an escrow account in exchange for 14 monthly payments of $6,576. The Company will receive the shares of common stock after all of the payments have been made. The Company made no payments during the nine months ended September 30, 2013, no payments in 2012, and $2,069 in 2011. The outstanding balance at September 30, 2013 was $90,000.
On January 18, 2013, All American Pet Company, Inc. (the “Company”) filed an action entitled All American Pet Company, Inc. vs. Eric Grushkin et al, in the Superior Court of the State of California, County of Los Angeles, West District against defendant Eric Grushkin (Case Number: SC119776). As previously announced, on January 11, 2013, the Company was made aware that a former employee sent communications that contained intentionally misleading and harmful disclosures as well as confidential information regarding the Company to a selected group of shareholders. These communications included allegations that the Company’s chief executive officer and president engaged in acts of malfeasance, misfeasance and negligence in the management and conduct of the Company business. The Company believes that this employee made multiple unauthorized disclosures of confidential information and misinformation to these shareholders on January 10, 2013 and thereafter. The complaint seeks damages and injunctive relief for:
|
2.
|
misappropriation of trade secrets
|
|
3.
|
intentional interference with prospective economic advantage
|
|
4.
|
breach of fiduciary duty
|
|
5.
|
violation of computer fraud and abuse act, and
|
Motions made by the defendant to remove to U.S. District Court and then to Dismiss have been denied. Other motions by the defendant have also been denied. This matter is currently pending in California State Court.
Item 1A. Change in Risk Factors.
There are no material changes in Risk Factors from the Form 10-K for year-end December 31, 2012 filed on June 17, 2013.
Item 2. Unregistered Sales of Equity Securities.
During the nine months ended September 30, 2013, the Company received and accepted subscriptions for 246,955,267 shares of common stock. 2,500,000 of these subscriptions were accepted at $0.02 per share and 244,455,267 were accepted at $0.007 per share. The sale of unregistered equity securities resulted in a capital increase of $1,113,731, before offering costs. The Company had previously recorded a $527,216 common stock payable on its books at June 30, 2013 to reflect the value of 49,828,429 of common shares not yet issued related to subscriptions sold during the quarter ended June 30, 2013 which shares were issued during the quarter ended September 30, 2013. The Company sold the shares without registration under the Securities Act of 1933, as amended, or state securities laws, in reliance on the exemptions provided by Section 4(2) of the Securities Act of 1933 and/or Regulation D promulgated thereunder. There were no more than 35 purchasers of the common stock, appropriate financial and business information was provided to the purchasers in accordance with Rule 502(b), there was no form of general solicitation or general advertising relating to the offer and the Company exercised reasonable care to assure that the purchasers of the common stock were not underwriters within the meaning of section 2(a)(11) of the Securities Act. Based on information received, the Company believes that each purchaser of shares is an accredited investor within the meaning of the federal securities laws. The shares have not been registered. The shares may not be offered or sold by the investors absent registration or an applicable exemption from registration requirements, such as the exemption afforded by Rule 144 under the Securities Act of 1933.
Shares issued for services totaled 294,368,549 and were valued at $2,032,037. These services were fully provided during the period ended September 30, 2013 and thus were fully amortized.
As of September 30, 2013, there were 1,296,159,433 shares issued and outstanding. As of February 24, 2013, the Company had 1,421,917,109shares of common stock outstanding.
On February 12, 2013, the Company entered into an unsecured, Convertible Promissory Note (the “Convertible Note”) with an unrelated third party for $103,500. The Convertible Note bears interest at 8% per annum and a balloon payment of principal and accrued interest is due on November 12, 2013. At any time 180 days after the date of the Convertible Note, the lender can convert the principal and accrued interest into shares of the Company’s common stock at a 39% discount based on the average of the lowest three trading prices during a ten day period ending one day prior to the conversion date. Pursuant to the terms of the Convertible Note, the Company must meet all of its filing requirements with the Securities and Exchange Commission. During the period, the Company was late on one of its filings and as a result the Convertible Note went into default. As provided for in the Convertible Note, it became a demand note and demand was made, the amount due became $159,390 which amount is composed of 150% of the principal amount or $155,250 which amount is composed of the principal amount of $103,500 and the default interest amount of $51,750, and the accrued interest of $4,140. During the quarter ended September 30, 2013, the entire principal amount of $103,500 together with $6,500 of interest for an aggregate amount of $110,000 was converted into 49,341,200 shares of the Company’s common stock. Further, as of October 22, 2013, the balance of $49,390 in interest was converted into 36,751,282 shares of the Company’s common stock. Finally, the intrinsic value of the beneficial conversion feature associated with the Convertible Note was $78,204 which amount was recorded as debt discount on the commitment date. As a result of the conversion of the entire principal and interest due, the Company fully amortized the debt discount during the period ended September 30, 2013 and $78,204 in debt discount was recognized as interest expense during the period ended September 30, 2013.
On September 17, 2013, the Company entered into an unsecured, Convertible Promissory Note (the “Convertible Note”) with an unrelated third party for $103,500. The Convertible Note bears interest at 8% per annum and a balloon payment of principal and accrued interest is due on June 19, 2014. At any time 180 days after the date of the Convertible Note, the lender can convert the principal and accrued interest into shares of the Company’s common stock at a 39% discount based on the average of the lowest three trading prices during a ten day period ending one day prior to the conversion date. The intrinsic value of the beneficial conversion feature associated with the Convertible Note was $66,172 which amount was recorded as debt discount on the commitment date and will be amortized over the life of the Convertible Note. For the period ended September 30, 2013 the Company recorded $3,808 of the debt discount as interest expense. Subsequent to the quarter ended September 30, 2013, during November 2013, the Company was late on one of its filings and as a result the Convertible Note went into default. Pursuant to the terms of the Convertible Note, the Company must meet all of its filing requirements with the Securities and Exchange Commission and as provided for in the Convertible Note, it became a demand note and demand was made during November 2013. The amount due became $159,390 which amount is composed of 150% of the principal amount or $155,250 which amount is composed of the principal amount of $103,500 and the default interest amount of $51,750, and accrued interest of $4,140. The Company has made no payments on the Convertible Note.
On March 6, 2012, the Board of Directors, consisting of Mr. Schwartz and Ms. Bershan, authorized the Company to execute a Convertible Revolving Grid Note (the “Grid Note”) for a principal sum of up to $1,000,000 with CEO Barry Schwartz and President, Lisa Bershan. The Grid Note bears interest at 10% per year and may be converted into common stock of the Company at a conversion price of $0.0022 any time before March 6, 2013. Neither Mr. Schwartz nor Ms. Bershan has advanced capital under the terms of the grid note as of December 31, 2012. In March 2013, the Grid Note was amended. On February 26, 2013, the Board of Directors authorized the Company to amend the Convertible Revolving Grid Note for a principal sum of up to $1,000,000 with Chief Executive Officer Barry Schwartz and President Lisa Bershan dated March 6, 2012. The amendment reduced interest to 6.5% per year, extended the maturity date to 4 years, and extended the conversion date to October 31, 2013. As of September 30, 2013, Mr. Schwartz and Ms. Bershan have loaned $624,064 with $15,106 accrued interest. Under the terms of the Grid Note and such amount is convertible into 290,531,696 shares of the Company’s common stock.
The terms of the Grid Note provide that the conversion price be lowered upon the occurrence of certain defined events. Notwithstanding this fact, the embedded conversion right is not required to be bifurcated from the host debt instrument, as the underlying common stock is not deemed to be readily convertible to cash (Accounting Standards Codification 815-15-25-51) based on management’s evaluation of the trading volume of the Company’s common stock and the lock up provisions of the Grid Note.
The conversion price of the Grid Note was below the closing market price of the Company’s common stock at the tie of related borrowings. As a result, the Company recognized beneficial conversion features, which were limited to the amount of the Grid Note borrowings of $624,064. The beneficial conversion features are being amortized to interest expense over the term of the Grid Note (March 2016). During the nine months ended September 30, 2013, interest expense related to the amortization of beneficial conversion features totaled $76,980.
During the nine months ended September 30, 2013 and year ended December 31, 2012, the Company made advances to, and received advances from, an entity owned by the Company’s Chief Executive Officer. These advances are not collateralized and do not bear interest. As of September 30, 2013 and December 31, 2012, no amounts were due from and no amounts were due to this related entity.
Item 3. Defaults Upon Senior Securities.
As described in Note 6 to the September 30, 2013 condensed consolidated financial statements, the Company is in default of a $50,000 note. Also described in Note 6 to the September 30, 2013 condensed consolidated financial statements, the Company was in default of a $103,500 convertible note dated February 12, 2013, which note was fully converted into shares of the Company’s common stock during the quarter ended September 30, 2013. Finally, as described in Note 6 to the September 30, 2013 condensed consolidated financial statements, the Company is in default of a $103,500 convertible note dated September 17, 2013 because it was late meeting SEC filing dates.
As described in Note 9 to the September 30, 2013 condensed consolidated financial statements, the Company is subject to various litigation, claims and judgments.
Item 4. Mine Safety Disclosures.
None.
Item 5. Other Information.
None.
Item 6. Exhibits.
|
|
|
|
|
|
Incorporated by reference
|
|
Exhibit
Number
|
|
Exhibit Description
|
|
Filed
Herewith
|
|
Form
|
|
Period
Ending
|
|
Exhibit
|
|
Filing
date
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31
|
|
Certification pursuant to Section 302 of the Sarbanes-Oxley Act
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32
|
|
Certification pursuant to Section 906 of the Sarbanes-Oxley Act
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.INS **
|
|
XBRL Instance Document
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.SCH **
|
|
XBRL Taxonomy Extension Schema Document
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.CAL **
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.DEF **
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.LAB **
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.PRE **
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
x
|
|
|
|
|
|
|
|
|
|
** XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
ALL AMERICAN PET COMPANY, INC.
|
|
|
(Registrant)
|
|
|
|
|
Date: March 14, 2014
|
By:
|
/s/ Barry Schwartz
|
|
|
|
Barry Schwartz, CEO
|
|
|
|
(On behalf of the registrant and as
Principal Financial and Accounting Officer)
|
|
28